Monoclonal antibody | |
---|---|
Type | Whole antibody |
Source | Mouse |
Target | MST1R (aka RON) |
Clinical data | |
ATC code |
|
Identifiers | |
CAS Number | |
ChemSpider |
|
UNII | |
KEGG | |
Chemical and physical data | |
Formula | C6454H10026N1754O2020S44 |
Molar mass | 145922.10 g·mol−1 |
![]() ![]() |
Narnatumab is a human monoclonal antibody designed for the treatment of cancer.[1] Clinical development was abandoned after phase I trials.[2][3]
Narnatumab was developed by ImClone Systems.
![]() | This monoclonal antibody–related article is a stub. You can help Wikipedia by expanding it. |
![]() | This antineoplasticorimmunomodulatory drug article is a stub. You can help Wikipedia by expanding it. |